JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
CALL
Ecolab
ECL
$78.1B
| $2.57M | ﹤0.01% |
13,300
-21,400
| -62% | -$4.06M |
|
3052
Tennant Co
TNC
$1.18B
| $2.56M | ﹤0.01% |
32,912
+12,547
| +62% | +$935K |
|
3053
PUT
Crown Castle
CCI
$31.5B
| $2.56M | ﹤0.01% |
18,000
| – | – |
|
3054
Cimpress
CMPR
$2.4B
| $2.56M | ﹤0.01% |
20,320
+2,615
| +15% | +$340K |
|
3055
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$590M
| $2.55M | ﹤0.01% |
80,267
-16,928
| -17% | -$534K |
|
3056
First Business Financial Services
FBIZ
$593M
| $2.55M | ﹤0.01% |
96,763
+1,038
| +1% | +$25.7K |
|
3057
Under Armour Class C
UA
$2.2B
| $2.55M | ﹤0.01% |
132,796
+22,256
| +20% | +$392K |
|
3058
Amalgamated Financial
AMAL
$1.52B
| $2.54M | ﹤0.01% |
130,550
-6,823
| -5% | -$126K |
|
|
THOR
3059
DELISTED
Synthorx, Inc. Common Stock
THOR
| $2.54M | ﹤0.01% |
36,351
+33,214
| +1,059% | +$949K |
|
3060
O-I Glass
OI
$1.04B
| $2.54M | ﹤0.01% |
212,674
-67,991
| -24% | -$678K |
|
3061
CALL
International Paper
IP
$21.8B
| $2.53M | ﹤0.01% |
58,080
| – | – |
|
|
3062
PUT
International Paper
IP
$21.8B
| $2.53M | ﹤0.01% |
58,080
| – | – |
|
|
IRBT
3063
CALL
DELISTED
iRobot
IRBT
| $2.53M | ﹤0.01% |
+50,000
| New | +$2.51M |
|
3064
West Bancorporation
WTBA
$503M
| $2.53M | ﹤0.01% |
98,803
+10,936
| +12% | +$260K |
|
3065
Safety Insurance
SAFT
$1.52B
| $2.53M | ﹤0.01% |
27,331
-30,682
| -53% | -$2.99M |
|
3066
CALL
Costco
COST
$421B
| $2.53M | ﹤0.01% |
8,600
-8,000
| -48% | -$2.38M |
|
|
VIVO
3067
DELISTED
Meridian Bioscience Inc
VIVO
| $2.53M | ﹤0.01% |
258,837
-430,850
| -62% | -$4.04M |
|
|
VG
3068
DELISTED
Vonage Holdings Corporation
VG
| $2.53M | ﹤0.01% |
341,142
+12,628
| +4% | +$109K |
|
3069
Ascendis Pharma A/S
ASND
$16.8B
| $2.53M | ﹤0.01% |
18,165
+10,940
| +151% | +$1.22M |
|
|
SGMO
3070
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.52M | ﹤0.01% |
301,633
+193,444
| +179% | +$1.78M |
|
|
SOHU
3071
Sohu.com
SOHU
$369M
| $2.52M | ﹤0.01% |
225,693
-66,670
| -23% | -$698K |
|
3072
CALL
AB InBev
BUD
$156B
| $2.52M | ﹤0.01% |
30,700
+1,500
| +5% | +$125K |
|
3073
Resources Connection
RGP
$144M
| $2.52M | ﹤0.01% |
154,136
+56,198
| +57% | +$854K |
|
|
NSTG
3074
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.51M | ﹤0.01% |
90,259
+77,616
| +614% | +$1.88M |
|
3075
iShares Expanded Tech Sector ETF
IGM
$10.9B
| $2.51M | ﹤0.01% |
62,184
-41,994
| -40% | -$1.6M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.